Innovation with Baycox®

Baycox® (toltrazuril) is the result of Bayer research efforts. Thanks to its characteristics, it represents a new standard in coccidiosis control products.

Baycox® belongs to the chemical group of “symmetric triazinons” and is not chemically related to any other anticoccidial drug currently used in veterinary medicine.

Due to its particular mode of action, which affects all intracellular structures of Coccidia, Baycox® demonstrates very high efficacy, as shown by the following benefits:

• prevents or reduces the severity of lesions,
• stops oocyst shedding,
• improves growth rate,
• improves feed conversion.

These product characteristics make Baycox® suitable for both therapy and metaphylaxis in domesticated animals.

Baycox® represents a very important tool in the control of coccidia problems.